Our Research


lieyr voieyr piaery oueys oiesyb isd piu ydrpiuydh

Pushing the edge of our understanding

Our mission is to conduct world-class medical research for the prevention of infectious diseases.


Our Research Focus

Our teams focus on three key areas that address major issues facing public health today.

These major issues are:

  1. Rapid development of antimicrobial resistance in microbial pathogens and their spread around the world.
  2. Emergence of novel pathogens and the requirement for new diagnostic and therapeutic interventions.

Our responses

  1. Identification and tracing: genomics and epidemiology
  2. Reducing time to treatment: novel diagnostic technology
  3. Developing new treatments: novel intervention strategies

Genomics and epidemiology

Associate Professor Allison Imrie and student

Associate Professor Allison Imrie

and PhD student Melissa Koh


Infectious diseases are continually evolving the means to escape treatment by antibiotics or vaccination. New emerging infections such as SARS CoV-2 and African swine fever are threatening the stability of the world economy in devastating ways. To assist the global responses to these issues, our experts use cutting-edge technologies such as sequencing and bioinformatics to understand the epidemiology of these diseases.

Understanding epidemiology enhances our ability to understand which control measures by public health are the most effective at suppressing the spread of infectious diseases.

The Kahler Lab

Associate Professor Charlene Kahler
introduces us to her lab

Novel Diagnostic Technology

Professor Barry Marshall, Dr Alfred Tay and their team working on Helicobacter Pylory

Professor Barry Marshall, Dr Alfred Tay,

Dr Eng Guan Chua and Binit Lamichhane - Helicobacter Research Laboratory


The successful outcomes for treatment of infectious disease rely on rapid diagnostic tests necessary to accurately and sensitively detect pathogens in clinical samples. This requires the improvement of the technology being applied to the problem in an iterative way to ensure the assays remain appropriate for deployment in many settings, including diagnostic laboratories or in general practice in metropolitan or remote areas.

Noisy Guts Project

headed by Nobel Laureate Professor Barry Marshall 
The project could help avoid invasive colonoscopies. The user wears an acoustic belt that listens, records and analyses gut noises with the aim of faster and more effective diagnoses for chronic gut disorders.

Novel Intervention Strategies

Dr Kate Hammer and student

Dr Kate Hammer

and PhD student Kathryn Green


Antimicrobial resistant infections are predicted to be the most common cause of death in our hospitals in the next 30 years. We are also witnessing the emergence of novel infectious diseases, such as
SARS CoV-2, which require us to rapidly search for appropriate therapies to treat ill patients.

The Nicol Lab

Professor Mark Nicol
explains about his lab and research

Our Team

healing            Manfred Beilharz

dna                         Geoff Coombs

dnahealing Lucy Furfaro

dnamicroscopeAllison Imrie

dnahealingCharlene Kahler

microscope            Samuel Lundin

microscope            Josephine Muir   

microscope            Chris Peacock   

dnamicroscope David Smith

healing             Mitali Sarkar Tyson   



healingBarbara Chang

microscope            Alma Fulurija

healing            Kate Hammer 

microscope            Tim Inglis

dna                         Daniel Knight

microscopehealing Shakeel Mowlaboccus

microscope healingMark Nicol

dnamicroscopeThomas Riley

microscope             Alfred Tay

dna Michael Wise

Our Global Network of Research Collaboration

Our research leaders have an extensive global network of collaborators, ensuring we have the necessary links to make an impact around the world.

                        Back to top
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.